EquiliBio
Targeted immune control for healthier aging

Rebalancing inflammation with next generation cytokine inhibitors to slow biological aging and extend healthspan

Mission

Chronic inflammation is sneaky — it quietly raises the risk of everything from cancer to heart disease, pulling the strings behind many of the conditions we accept as “just aging” and accelerating age-related pathologies.

At EquiliBio, we’re developing targeted immune-modulating solutions to keep inflammation in check, protect long-term health, and redefine what healthy aging can look like. Because extending lifespan matters… but improving the years we live matters even more.

The Inflammation Problem

As we grow older, the immune system gradually enters a state of persistent activation. This state, called “inflammaging,” disrupts tissue repair, decelerates biological functions, and contributes to frailty, metabolic imbalances, and reduced physiological resilience.

Individually, modern medicine has made remarkable progress treating age-related diseases, but the underlying inflammatory biology remains largely unaddressed.

Targeting inflammation represents a powerful opportunity to improve health-span, not just life-span — shifting care from reactive to preventative, and from late-stage treatment to early, proactive intervention.

Our Approach

Our approach integrates advanced biologics, immune modulation strategies, and deep profiling of aging-related immune signatures. By focusing on the regulators of chronic inflammation, we aim to slow age-associated decline at its source rather than treating its symptoms.

Immunology

understanding how inflammatory signals shift with age and how they can be modulated safely and precisely.
Advanced biologics

leveraging modern tools to intervene selectively in specific inflammatory pathways
Translational models

from controlled experimental systems to real-world environments, enabling us to measure functional improvements in resilience, vitality, frailty and biological aging.
Biomarker-driven insights

using multi-omic and functional readouts to quantify health-span, not just disease endpoints.

The goal is simple: Develop safe, effective interventions that help the body maintain balanced inflammation, preserve function, and age more slowly.

Research Pipeline

Developing oral, highly specific cytokine inhibitors designed for safe, long-term immune modulation. Our approach targets inflammatory pathways with precision, offering a new class of therapies that can be taken easily, work selectively, and support healthier aging without compromising immune defense.